Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Microneedle, An Innovative Approach to Transdermal Drug Delivery


Affiliations
1 Kamla Nehru College of Pharmacy, Butibori, Nagpur, Pin-441122. India (M.S)., India
2 Priyadarshini J. L College of Pharmacy, MIDC, Electronic Zone Building, Hingna Road, Nagpur, Pin-444016, India
     

   Subscribe/Renew Journal


Transdermal drug delivery system (TDDS) is a newer technique which offer delivery of drug via skin at controlled rate and prolong duration. Microneedles (MNs) are the recent advancement in the TDDS which can deliver high molecular weight drug by penetrating into the skin. MNs become popular due to avoidance of first pass metabolism, good patient compliance, rapid, easy and painless administration. Solid, coated, hollow, dissolvable and hydrogel-forming are the types of MNs having their own merits and demerits. MNs are generally prepared from silicon and used to deliver drugs, hormones, peptides, protein, vitamin, plasmid DNA, and vaccine in a safe and effective way. The working principle and the four different strategies for TDDS using a MNs array are poke and patch, coat and poke, poke and released, poke and flow technique. At present number of preclinical and clinical research is going on for the enhancement of permeability, stability and delivery of drug using MNs. This review focused on the types, manufacturing, current status and method of evaluation of MN in pharmaceutical research.

Keywords

Transdermal Drug Delivery System, Microneedle, Biodegradable Microneedle, Painless Drug Delivery.
Subscription Login to verify subscription
User
Notifications
Font Size


  • Shingade et al. Recent Trend on Transdermal drug delivery system: A review: Journal of Drug delivery and therapeutics. 2012; 2(1): 66-71.
  • Bhowmik et al. Recent advances in transdermal drug delivery system: International Journal of Pharm Tech Research. 2010; 2(1): 68-77.
  • Ashaf MW, Tayyaba S, Afzulpurkr N. Tapered tip hollow silicon microneedles for transdermal drug delivery: In Mechanical and Electronics Engineering (ICMEE), 2010 2nd International Conference on 2010.
  • Prabhakar D, Shreekanth J, Jayaveera K. Transdermal Drug Delivery Patches: A Review. J Drug Del and Therapeutics.. 2013; 3(4), 213-221.
  • Prausnitz M.R, Langer R, Transdermal drug delivery: Nature biotechnology. 2008; 26 (11): 1261-1268.
  • Henry S. et al., Microfabricated microneedles: a novel approach to transdermal drug delivery: Journal of Pharmaceutical Sciences. 1998; 87(8): 922-925.
  • Gardeniers H. et al. Silicon Micro machined hollow microneedles for transdermal liquid Transport: Journal of Micro electromechanical System. 2003; 12(6): 855-862.
  • Donnelly RF. Hydrogel-forming microneedle arrays for enhanced transdermal drug delivery. Advanced Functional Material. 2012; 22: 4879–4890.
  • Donnelly RF et al. Hydrogel-forming microneedle arrays can be effectively inserted in skin by self-application: a pilot study centred on pharmacist intervention and a patient information leaflet. Pharmaceutical Research. 2014; 1–11.
  • Tuan-Mahmood TM et al., Microneedles for intradermal and transdermal drug delivery. European Journal of Pharmaceutical Science. 2013; 50(5); 623–637.
  • Quinn HL et al. The role of microneedles for drug and vaccine delivery. Expert Opinion in Drug Delivery. 2014; 11: 1769–1780.
  • Chandrasekhar S et al. Microarrays and microneedle arrays for delivery of peptides, proteins, vaccines and other applications. Expert Opin. Drug Deliv, 2013; 10: 1155–1170.
  • Rohan D. et al. Microneedle Technology for Advanced Drug Delivery: A Review: International Journal of Pharmacy and Technical Research. 2012; 181-189.
  • McAllister DV. Microfabricated needles for transdermal delivery of macromolecules and nanoparticles fabrication methods and transport studies: Proceedings of the National Academy of Sciences of the United States of America. 2003;100: 13755-60.
  • ALZA website, http://www.alza.com/, Retrieved.
  • Kalluri H and Banga A.K. Formation and closure of microchannels in skin following microporation: Pharmaceutical research. 2011; 28(1): 82-94.
  • Kapoor D, Patel M, Singhal M. Innovations in transdermal drug delivery system: International journal of Pharmaceutical Science. 2011; 1(1): 54-61.
  • Gill HS and Prausnitz MR. Coated microneedles for transdermal delivery: Journal of controlled release. 2007; 117(2): 227-237.
  • Mikszta JA. et al. Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery: Nature medicine, 2002; 8(4): 415-419.
  • Kochhar JS. et al. Direct Microneedle Array Fabrication off a Photomask to Deliver Collagen Through Skin: Pharmaceutical research. 2014; 1-11.
  • Lee JW, Park JH, and Prausnitz M.R. Dissolving microneedles for transdermal drug delivery: Biomaterials. 2008; 29 (13): 2113-2124.
  • Griss P, Stemme G. Side-opened out-of-plane microneedles for microfluidic transdermal liquid transfer: Microelectromechanical Systems. 2003; 12(3): 296-301.
  • Prausnitz MR, Mitragotri S, Langer R. Current status and future potential of transdermal drug delivery: Nature Review Drug Discovery. 2004; 3: 115-124.
  • Srinivas P, Shanthi CL, Sadanandam MS. Miconeedles patches in drug delivery: a review. International Journal of PharmTech. 2010; 2(3): 329-344.
  • Kaushik S. et al. Lack of pain associated with microfabricated microneedles: Anesthesia and Analgesia, 2001; 92: 502–504.
  • Donnelly RF. Et al. Photochem Photobiol. 2009; 85 195–204.
  • Oh JH. European Journal of Pharmaceutics and Biopharmaceutics. 2008; 69 1040–1045.
  • Martanto W. et al. Transdermal delivery of insulin using microneedles in vivo: Proceedings of International Symposium on Controlled Release Bioactive Material. 2003; 666.
  • Vinayakumar, KB. Development of cup shaped microneedle array for transdermal drug delivery: Biointerphases. 2015; 10: 021008.
  • Kaur M. et al. Microneedle-assisted delivery of verapamil hydrochloride and amlodipine besylate: European Journal of Pharmaceutics and Biopharmaceutics. 2014; 86: 284–291.
  • Ahmad R. et al. Microneedle Coating Techniques for Transdermal Drug Delivery. Pharmaceutics. 2015 Dec; 7(4): 486–502.
  • Kim NW. et al., Polyplex-releasing microneedles for enhanced cutaneous delivery of DNA vaccine: J. Control. Release. 2014; 179: 11–17.
  • Donnelly RF. et al. Microneedle-Mediated Transdermal and Intradermal Drug Delivery, Wiley, 2012.
  • Donnelly RF, et al. PLOS ONE, 2014; 9e111547.
  • Lee JY. et al. Rapid and repeatable fabrication of high A/R silk fibroin microneedles using thermally-drawn micromolds: European Journal of Pharmaceutics and Biopharmaceutics. 2015; 94, 11–19.
  • Chen MC. et al. Near-infrared light responsive composite microneedles for on-demand transdermal drug delivery: Biomacromolecules. 2015; 16, 1598–1607.
  • Hong X et al. Dissolving and biodegradable microneedle technologies for transdermal sustained delivery of drug and vaccine Drug Design Development and Therapy. 2013; 7945–952.
  • Chien YW and Lambert HJ. U.S. Patent No.3, March 23, 1976; 946.
  • Mortazawi SA, and Reza A. An Investigation into the Effect of Various Penetration Enhancers on Percutaneous Absorption of PiroxicamIranian Journal of Pharmaceutical Research. 2003; 135-140.
  • Verbaan FJ. et al Improved piercing of microneedle arrays in dermatomed human skin by an impact insertion method: Journal of Control Release. 2008; 128: 80–88.
  • Ovsianikov et al. Two Photon Polymerization of Polymer–Ceramic Hybrid Materials for Transdermal Drug Delivery. International Journal of Applied Ceramic Technology. 2007; 4 22–29.
  • Wang PM. et al. journal of Investigative Dermatology. 2006; 126: 1080–1087.
  • Smart WH and Subramanian K. The use of silicon microfabrication technology in painless blood glucose monitoring Diabetes Technology and Therapy. 2000; 2: 549– 559.
  • Chen J and Wise KD. A multichannel neural probe for selective chemical delivery at the cellular level: IEEE Transaction on Biomedical Engineering. 1997; 44: 760– 769.
  • Yuzhakov VV. The AdminPen™ microneedle device for painless & convenient drug delivery: Drug Delivery Technology. 2010; 10: 32–36.
  • Jun H. et al. Use of hollow microneedles for targeted delivery of phenylephrine to treat fecal incontinence: Journal of Control Release. 2015; 207: 1–6.
  • Donnelly R. et al. Microneedles/ Delivery Device and Method, 2007.
  • HashmI S. et al. Genetic transformation of nematodes using arrays of micromechanical piercing structures: BioTechniques, 1995; 19: 766–770.
  • Eneko L. et al. Microneedle arrays as transdermal and intradermal drug delivery systems: Materials science, manufacture and commercial development. Materials Science and Engineering. 2016; 104: 1–32.
  • Henry S. et al. Microfabricated Microneedle: A Novel Approach to Transdermal Drug Delivery: Journal of Pharmaceutical Sciences, 1998; 87: 922-925.
  • Lin W. et al. Transdermal delivery of antisense oligonucleotides with microprojection patch (Macroflux) technology, pharmaceutical Research. 2001;18: 1789-1793.
  • Cormier M and Daddona PE. Macroflux technology for transdermal delivery of therapeutic protein s and vaccines, in MJ Rathbone, J Hadgraft, MS Roberts (Eds.), Modified- release drug delivery technology:Marcel Dekker, New York 2003; 589-598.
  • Park KY. et al. Efficacy and safety of a new microneedle patch for skin brightening: A Randomized, split-face, single-blind study. J Cosmet Dermatol. 2017; 16(3): 382-387 54. http://www.cosmed-pharm.co.jp/.
  • http://www.sheiseido.co.jp
  • http://www.sanofi.com
  • http://www.clinicaltrial.gov
  • http://www.nanopass.com/content-c.asp?cid=22
  • Hirobe S. et al., Development and clinical study of a self-dissolving microneedle patch for transcutaneous immunization device: Pharmaceutical research. 2013; 30(10): 2664-2674.
  • Barry B.W. Novel mechanisms and devices to enable successful transdermal drug delivery: European Journal of Pharmaceutical Science. 2001; 14: 101-114.
  • Schramm J and Mitragotri S. Transdermal drug delivery by jet injectors: energetics of jet formation and penetration. Pharmaceutical Research. 2002; 19: 1673-79.
  • Murthy SN. Magnetopheresis for enhancing transdermal drug delivery. Pharmazie. 1999; 54(5): 377-379.
  • Ita K. Transdermal delivery of drugs with microneedles: Strategies and outcomes: Journal of Drug Delivery Science and Technology. 2015; 29: 16–23.

Abstract Views: 168

PDF Views: 0




  • Microneedle, An Innovative Approach to Transdermal Drug Delivery

Abstract Views: 168  |  PDF Views: 0

Authors

N. A. Arsod
Kamla Nehru College of Pharmacy, Butibori, Nagpur, Pin-441122. India (M.S)., India
P. N. Amale
Priyadarshini J. L College of Pharmacy, MIDC, Electronic Zone Building, Hingna Road, Nagpur, Pin-444016, India
S. S. Borkar
Kamla Nehru College of Pharmacy, Butibori, Nagpur, Pin-441122. India (M.S)., India

Abstract


Transdermal drug delivery system (TDDS) is a newer technique which offer delivery of drug via skin at controlled rate and prolong duration. Microneedles (MNs) are the recent advancement in the TDDS which can deliver high molecular weight drug by penetrating into the skin. MNs become popular due to avoidance of first pass metabolism, good patient compliance, rapid, easy and painless administration. Solid, coated, hollow, dissolvable and hydrogel-forming are the types of MNs having their own merits and demerits. MNs are generally prepared from silicon and used to deliver drugs, hormones, peptides, protein, vitamin, plasmid DNA, and vaccine in a safe and effective way. The working principle and the four different strategies for TDDS using a MNs array are poke and patch, coat and poke, poke and released, poke and flow technique. At present number of preclinical and clinical research is going on for the enhancement of permeability, stability and delivery of drug using MNs. This review focused on the types, manufacturing, current status and method of evaluation of MN in pharmaceutical research.

Keywords


Transdermal Drug Delivery System, Microneedle, Biodegradable Microneedle, Painless Drug Delivery.

References